Table 4.
Group | IL-6 (pg/ml) | CRP (mg/L) | TNF-α (ng/L) | IL-1β (ng/L) | PGE2 (μg/L) | |||||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
||||||
Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment | |
Study Group B (n=40) | 53.28±6.36 | 32.52±4.78 | 2.31±0.42 | 1.57±0.20 | 25.26±3.77 | 10.34±1.78 | 86.31±17.56 | 50.12±10.22 | 366.54±27.68 | 226.78±19.67 |
Study Group A (n=40) | 53.42±6.71 | 37.45±5.23 | 2.28±0.37 | 1.98±0.22 | 25.34±3.68 | 17.25±2.13 | 87.26±17.88 | 56.92±12.81 | 364.31±29.60 | 255.74±23.55 |
Control group (n=40) | 3.59±1.12a,b | / | 1.26±0.18a,b | / | 0.91±0.12a,b | / | 4.31±1.26a,b | / | 43.78±10.57a,b | / |
T/F | 1139.282 | 4.764 | 120.507 | 8.818 | 859.278 | 15.783 | 426.776 | 2.630 | 2364.750 | 6.032 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.010 | < 0.001 | < 0.001 |
Note: IL-6: Interleukin-6, CRP: C-reactive protein, TNF-α: tumor necrosis factor alpha, IL-1β: Interleukin-1β, PEG2: prostaglandin E2.
P < 0.05, compare with group B;
P < 0.05, compare with group A.